MEDFORD, N.Y., Feb. 24, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced receipt of a ...
HAUPPAUGE, N.Y., May 17, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (CEMI) (Chembio) (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced ...
MEDFORD, N.Y., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced completion of the ...
A Hauppauge manufacturer of HIV tests has won a $2.7 million judgment against a former distributor in the United Kingdom. Chembio Diagnostics Inc. said this week that an arbitration tribunal found its ...
Chembio Diagnostics Inc. announced Wednesday that two European businesses will begin selling HIV self-test kits using the Medford company's technology. The European products are based on Chembio's ...
Thinly traded nano cap Chembio Diagnostics (CEMI-13.1%) is down on modestly higher volume, only 148K shares, on the heels of an update on its U.S. marketing application for its DPP HIV-Syphilis Assay ...
Larry Siebert says he was simply trying to protect his investment in the company when, as a consultant and business broker, he became chairman of Chembio Diagnostic Systems back in 1992. Since then, ...
MEDFORD, N.Y., July 06, 2017 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that Gail S. Page ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results